Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-21

Clinical Trial Update: Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab

View source ↗

Summary

Completed Greek study evaluating quality-of-life outcomes in psoriasis patients treated with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2014-02-21